What The Relaxation In Access To Cannabis For Scientific Research Means For Medical Marijuana Development

MMJ Recs

The use of cannabis in scientific research in the US has been at a standstill for the last five decades. The limit on where scientists could access cannabis for research was limited to just one facility at the University of Mississippi. Cannabinoid research and development.

There’s a Newly Developed Psychometric Assessment of Cannabis Intoxication


Luckily, researchers have developed a new psychometric assessment that “incorporates contemporary young adult language to measure the effects of cannabis.” In order to evaluate this new scale, Cloutier and colleagues recruited 106 young adults as part of their research.


Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

Psychedelic Research Targets Systemic Inflammation

Project CBD

Scientists are targeting psychedelics to develop an anti-inflammatory wonder drug

CBD 267

2021 Connecticut Tax Developments

Cannabis Law Report

30 July 2021. by Louis B. Schatz (Hartford) , Alan E. Lieberman (Hartford), David O. Bigger (Hartford) and Raymond J. Casella (Hartford). Shipman & Goodwin LLP. Opportunity Lost?The The New State Biennial Budget. Connecticut adopted a $46.4

Canada: Research and Development Coordinator aphria inc.Leamington, ON

Cannabis Law Report

The post Canada: Research and Development Coordinator aphria inc.Leamington, ON first appeared on Cannabis Law Report. Are you looking for an exciting career in a thriving new industry that prides itself on innovation, professionalism, and collaboration? Here are Aphria inc.

Scientists in China Develop Non-hallucinogenic Compounds That Relieve Depression


Fortunately, Chinese scientists have developed non-hallucinogenic antidepressant compounds. A press release announcing the scientists’ research explains that the team has “designed two new compounds that can relieve depression but do not cause the unwanted effect of hallucination.”

CISW 2020 Day 1 – Panel Discussion “Research & Development for Medical Cannabis Purposes”

Cannabis Law Report

Panel Discussion “Research & Development for Medical Cannabis Purposes” – Panelists – Dr. Sandra Carrillo (Moderator) – (Medical Doctor, Professor, Co-Founder of Medicann … Read More.

Cannabidiol (CAS 13956-29-1) Global Market Research Report 2022: Trends and Developments, Prices, Patents, Major Players and Major Downstream Sectors – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “Cannabidiol (CAS 13956-29-1) Global Market Research Report 2022” report has been added to ResearchAndMarkets.com’s offering. This global report is a result of industry experts’ diligent work on researching the world market of Cannabidiol. The report helps to build up a clear view of the market trends and development, identify major players in the industry, and estimate main downstream sectors.

Press Release: Canada – Princeton mushroom research and development facility officially opens, sells first grow of psilocybin mushrooms

Cannabis Law Report

is a Canadian company that researches, develops and grows psilocybin-producing mushrooms and functional mushrooms.

Researchers To Investigate Arkansas’ Medical Cannabis Program


For the first time ever, researchers will conduct a comprehensive state population health analysis to understand the impact of medical cannabis on consumers’ healthcare —and it’s all happening in Arkansas.

Rapid Dose Therapeutics and McMaster University’s COVID-19 Vaccine Study Receives NSERC Research and Development Grant

Cannabis Law Report

We appreciate the ongoing support received from the Canadian government through NSERC as we continue to drive this important research forward,” said Mark Upsdell, CEO, Rapid Dose Therapeutics.

CBD research trends in 2019


It's getting easier for CBD researchers to conduct studies of cannabidiol. Here are some developing trends in CBD research that bear watching. The post CBD research trends in 2019 appeared first on Leafly. CBD Science & tech cbd research science

CBD 81

Press Release: Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness

Cannabis Law Report

Havn Life believes operations can advance its business plan and potentially accelerate production of naturally-derived psilocybin for global medical research.…

Brazil’s Cannabis Social and Economic Research Institute Launches Tech To Monitor Countrywide Legal Developments In Cannabis

Cannabis Law Report

Brazil’s IPSEC (Cannabis Social and Economic Research Institute) has launched a service that will monitor the legal environment involving cannabis… Read More.

New U.S. Research Efforts Could Catalyze Medical Cannabis’ Adoption in the Pharmaceutical Industry


federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Fortunately, the brakes are gradually being lifted on research opportunities. Challenges in Conducting Medical Cannabis Research Remain.

Swiss Life Sciences Group Develops Cannabis Genetics for Healthcare

Cannabis Law Report

Swiss Life Sciences Group Plc (SLSG) is pleased to announce its partnership with Switzerland’s leading cannabis and CBD genetics experts, Bio Zu Farm , who have been developing their own cannabis genetics for more than 25 years.

New Research Confirms How Cannabis Gets Its Skunky Smell


While many have speculated that the skunk smell could be attributed to the terpenes , or aromatic compounds, of cannabis, the research team behind the study actually discovered a whole new class of volatile sulfur compounds (VSCs) to thank for the cannabis-skunk phenomenon.

NFL to Award Research Grant to Investigate Cannabis Therapy


The National Football League has taken proactive steps moving forward into the future with a research grant to explore potential therapeutic attributes of CBD, cannabis, and other options to treat pain other than opioids. News Politics Research Treatment cannabis research nfl

Dyskinesia Drugs In Development Pipeline Report 2021 – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “Dyskinesia (Central Nervous System) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering. Dyskinesia – Therapeutics Development. Dyskinesia – Product Development Milestones.

Maine’s Office Of Marijuana Policy Publishes New Research and Development Transfer Manifest and Guidance on Packaging and Labeling Seeds

Cannabis Law Report

OMP Publishes New Research and Development Transfer Manifest and Guidance on Packaging and Labeling Seeds. View the Research and Development Transfer Manifest: Adult Use Applications and Forms.

Johns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals’ Supera-CBD at the 3rd Annual Neuroimmunology Drug Development Summit

Cannabis Law Report

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More. Business Wire

Noetic Commits to Investing $6.95M into Seed Round for The Alexander Shulgin Research Institute for Psychedelic Drug Discovery and Development

Cannabis Law Report

TORONTO, ON / ACCESSWIRE / December 9, 2021 / Noetic Fund led the Seed round for the Alexander Shulgin Research Institute Inc. The Alexander Shulgin Research Institute Inc. The Institute was informally founded by Dr. Shulgin in the 1980s to spotlight his research. The PR.

Research Finds That CBG Can Impede Glioblastoma Cell Growth


Glioblastoma can therefore be a brain or spinal cancer and is said to have a complex biology, despite decades of dedicated research on the matter. The aim of the team was to develop an effective cannabinoid combination and define the protocols for treating glioblastoma patients.

Article – Carib News: Guyana To Develop Hemp Industry

Cannabis Law Report

Agriculture Minister Zulfikar Mustapha said the Industrial Hemp Bill will “provide for the cultivating and manufacturing of industrial hemp and hemp-related products; to provide for the conducting of research and industrial hemp or any other activity concerning or relating to industrial hemp”.

Researchers Concerned About Whitewashing of Psychedelic-Assisted Mental Health Research

Cannabis Law Report

As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Whitewashing psychedelics: Racial equity in the emerging field of psychedelic-assisted mental health research and treatment.

Cannabinoids Could Limit Brain Injury Damage, Researchers Say

The Cannigma

Now, a research group at the Medical College of Georgia at Augusta University has been awarded a $1.8 The research group, led by principal investigator and translational neuroscientist Dr Kumar Vaibhav, has previously looked into the role of the endocannabinoid system following TBI.

cbdMD Therapeutics Releases Research Plan

Cannabis Law Report

The Company expects to finalize the agreement with the research institute and commence studies by Fall 2021. The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. Seeks To Identify Novel Cannabinoids For Therapeutic Use.

Agrify Enters Multiyear Vertical Farming Research and Development Partnership With Curaleaf


However, he said, “In any case, Clever Leaves is currently able to provide high THC, high CBD and balanced products to our clients, and also has the capabilities to develop a customized product in a reasonable period of time for our clients.”.

Virpax Pharmaceuticals Reports 2022 First Quarter Results and Recent Developments

Cannabis Law Report

Virpax” or the “Company”) (NASDAQ:VRPX) , today announced its financial results for the quarter ended March 31, 2022, and other recent developments. “We RECENT DEVELOPMENTS. Army Institute of Surgical Research (USAISR), the U.S. Research and development. . .

WSU researchers team with Puyallup tribe on medicinal cannabis research

Cannabis Chronicles

SPOKANE — Researchers at Washington State University are teaming up with the Puyallup Tribe of Indians in an effort to chart the tribe’s outcomes prescribing medicinal marijuana to patients. We’ll hand them an iPad, and ask them to fill out a couple quick surveys,” said Michael McDonell, chair of WSU’s Collaboration on Cannabis Policy, Research and Outreach. McDonell said research institutions are limited in their access to cannabis users by federal laws that could affect funding.

Director of Business Development and Partnerships Montreal Quebec Canada

Cannabis Law Report

CanMar Recruitment is looking for a Director of Business Development and Partnerships for our client in Montreal, Quebec. As Director of Business Development and Partnerships, you are responsible for leading and accelerating business analysis, sourcing, and deal flow activities.

Restless Legs Syndrome Drugs in Development, 2022 Market Research Report: Pipeline Landscape, Stages, Target, MoA, RoA, Molecule Type and Key Players – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “Restless Legs Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update” report has been added to ResearchAndMarkets.com’s offering. Therapeutics Development.

Study finds endocannabinoid system regulates sperm development


The latest research suggests the endocannabinoid system and male reproductive system share a complex and extensive connection, bringing scientists closer to understanding how cannabis affects men’s fertility. The post Study finds endocannabinoid system regulates sperm development appeared first on Leafly.

IGC Acquires Exclusive Rights for a Potential Alzheimer’s Drug Development Candidate

Cannabis Law Report

NYSE: IGC) is excited to announce that one of its subsidiaries reached an Intellectual Property (IP) license agreement for a potential Alzheimer’s drug development candidate. IGC acquired exclusive global rights to the molecule and plans to develop this NMI lead candidate further.

Research Surrounding the Effects of Cannabis on Heart Health Is Still Conflicting


Such extreme levels of heart problems signify a pressing need for research into the root cause(s), not to mention new treatment options. Researchers Examine Composite CVD Risk . Previous Research Highlights Cannabis’ Heart Health-Enhancing Properties.

Australia CSIRO moves into psychedelics research

Cannabis Law Report

Australia’s Commonwealth Scientific and Industrial Research Organisation has been issued a licence to conduct research into psychedelic drug treatments. Australian organisation announces licence and partnerships to investigate medicinal use of psychedelic drugs.

Congress Passes Bill Allowing Researchers To Study Commercial Cannabis


House of Representatives approved a bill on Friday that will allow researchers to study commercial cannabis sold in state-legal dispensaries instead of having to depend on government-grown cannabis, Marijuana Moment reports. The U.S.